arrow
C

Christopher A. Vakulskas

integrated dna technologies idt
H指数:33
被引数:5,517

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reprogramming site-specific retrotransposon activity to new DNA sites

将位点特异性逆转座子活性重编程至新的DNA位点

NATURE
IF48.5
2025-04-091
PRE
Genetically corrected RAG2-SCID human hematopoietic stem cells restore V(D)J-recombinase and rescue lymphoid deficiency

基因校正的RAG2-SCID人造血干细胞恢复V(D)J-重组酶和拯救淋巴缺陷

2024-04-091
OAAI
Propensity of Patient-Derived iPSCs for Retinal Differentiation: Implications for Autologous Cell Replacement

患者来源的ipsc对视网膜分化的倾向: 对自体细胞替代的影响

2023-05-238
OAAI
Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases

使用CRISPR指导的整合酶在没有双链DNA切割的情况下拖放大序列的基因组插入

2022-11-24197
OA
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines (vol 12, 3908, 2021)
2021-07-193
OAAI
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

AsCas12a超核酸酶促进治疗细胞药物的快速生成

2021-06-2377
OAAI
Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease
2021-06-1689
OA
Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells
2021-03-1853
OAAI
Identification of preexisting adaptive immunity to Cas9 proteins in humans
2019-01-28663
OAAI
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
2018-08-06595
OAAI